HM Payson & Co’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $4.07M | Buy |
55,333
+49,772
| +895% | +$3.66M | 0.07% | 112 |
|
|
2024
Q4 | $364K | Sell |
5,561
-59,953
| -92% | -$3.93M | 0.01% | 322 |
|
|
2024
Q3 | $5.1M | Buy |
65,514
+61,805
| +1,666% | +$4.82M | 0.09% | 108 |
|
|
2024
Q2 | $289K | Buy |
3,709
+14
| +0.4% | +$1.09K | 0.01% | 349 |
|
|
2024
Q1 | $250K | Buy |
3,695
+5
| +0.1% | +$339 | ﹤0.01% | 362 |
|
|
2023
Q4 | $249K | Sell |
3,690
-937
| -20% | -$63.1K | 0.01% | 352 |
|
|
2023
Q3 | $313K | Buy |
4,627
+2,268
| +96% | +$154K | 0.01% | 319 |
|
|
2023
Q2 | $169K | Buy |
2,359
+280
| +13% | +$20K | ﹤0.01% | 395 |
|
|
2023
Q1 | $144K | Sell |
2,079
-23
| -1% | -$1.6K | ﹤0.01% | 417 |
|
|
2022
Q4 | $143K | Buy |
2,102
+79
| +4% | +$5.36K | ﹤0.01% | 415 |
|
|
2022
Q3 | $111K | Hold |
2,023
| – | – | ﹤0.01% | 451 |
|
|
2022
Q2 | $134K | Sell |
2,023
-230
| -10% | -$15.2K | ﹤0.01% | 428 |
|
|
2022
Q1 | $149K | Buy |
2,253
+2,000
| +791% | +$132K | ﹤0.01% | 434 |
|
|
2021
Q4 | $15K | Hold |
253
| – | – | ﹤0.01% | 811 |
|
|
2021
Q3 | $15K | Hold |
253
| – | – | ﹤0.01% | 782 |
|
|
2021
Q2 | $15K | Sell |
253
-527
| -68% | -$31.2K | ﹤0.01% | 784 |
|
|
2021
Q1 | $39K | Sell |
780
-1,018
| -57% | -$50.9K | ﹤0.01% | 641 |
|
|
2020
Q4 | $90K | Buy |
1,798
+1,248
| +227% | +$62.5K | ﹤0.01% | 491 |
|
|
2020
Q3 | $30K | Buy |
+550
| New | +$30K | ﹤0.01% | 653 |
|